Atlas Trials

Effectiveness and Safety of InO±DLI for Relapsed B-ALL/LBL After Allo-HSCT

Clinical trial NCT06861348 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06861348
Sponsor
First Affiliated Hospital of Zhejiang University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Leukemia, Lymphocytic, Acute
Start date
2025-03-01
Primary completion
2026-04-30
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.